Skip to content

Author

Xin Wu

We have 2 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Combined Anti-PD-1/PD-L1 and Anti-angiogenic Therapy: An Emerging Direction for Future NSCLC Treatment

Combined therapy has become a pivotal direction in NSCLC systemic treatment and future research should prioritize optimizing treatment regimens, refining real-world safety assessments, and expanding clinical application in patients with complex comorbidities to address current unmet therapeutic needs.

Ming-Tai Li, Zhi-Qing Wu, Xin Zheng et al. · 0 citations
Review Aug 2026

Biomimetic delivery systems for overcoming drug resistance in gastrointestinal cancers.

By linking GI cancer-focused MDR biology to function-oriented biomimetic design, this review establishes an evidence-based framework for distinguishing delivery enhancement from true MDR reversal and outlines platform-specific requirements for clinical translation.

Gou Wu, Aixue Li, Yongwei Gu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.